:

QUANTINUUM TARGETS $1.05B IN US IPO

AI DESK1 MIN READ
TUE, MAY 26, 2026

■ AI-SUMMARIZED FROM 2 SOURCES ▸ TIMELINE

Quantinuum, a quantum computing company backed by Honeywell, filed to raise $1.05 billion through its US initial public offering. The company plans to market approximately 21 million shares priced between $45 and $50 each.

At the top of the proposed price range, Quantinuum would achieve a valuation of $12.7 billion. The IPO filing marks a significant step for the quantum computing sector, which has attracted substantial investment despite the technology remaining in relatively early stages of commercialization. Quantinuum was formed through the 2021 merger of Cambridge Quantum Computing and Honeywell Quantum Solutions. The company focuses on developing quantum computing hardware and software, positioning itself in a competitive landscape that includes IBM, Google, and other technology giants pursuing quantum capabilities. The pricing range and share count suggest the company expects robust investor demand. Final pricing details and trading commencement depend on SEC clearance and market conditions. The IPO would represent a notable validation of quantum computing's commercial potential, though the sector continues to navigate questions about near-term profitability and practical applications.

■ SOURCES

TechmemeBloomberg Tech

■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE

■ MORE FROM THE STARTUPS DESK

Triomics, an AI platform automating data-heavy tasks for oncologists, secured $22M in Series B funding. The raise follows a $15M Series A in 2024.

12H AGOAI Desk

Xcena secured $135 million in Series B funding at a $570 million valuation for its MX1 chip, which handles data orchestration and KV cache management directly within memory modules.

12H AGOAI Desk

Pittsburgh-based Gray Swan, which stress-tests AI models for frontier labs, secured $40M in Series A funding at a $200M valuation. The round was co-led by Wing VC and Madrona.

20H AGOAI Desk

H1, a healthcare SaaS startup, secured $40 million in funding from CVS Health. The investment signals continued investor confidence in specialized software platforms despite AI disruption concerns.

YESTERDAYIndustry Desk

■ SUBSCRIBE TO THE DAILY BRIEF

ONE EMAIL, 5 STORIES, 06:00 UTC. UNSUBSCRIBE ANYTIME.